SE9500422D0 - New oral pharmaceutical dosage forms - Google Patents

New oral pharmaceutical dosage forms

Info

Publication number
SE9500422D0
SE9500422D0 SE9500422A SE9500422A SE9500422D0 SE 9500422 D0 SE9500422 D0 SE 9500422D0 SE 9500422 A SE9500422 A SE 9500422A SE 9500422 A SE9500422 A SE 9500422A SE 9500422 D0 SE9500422 D0 SE 9500422D0
Authority
SE
Sweden
Prior art keywords
pct
dosage form
pharmaceutical dosage
oral pharmaceutical
dosage forms
Prior art date
Application number
SE9500422A
Other languages
English (en)
Inventor
Helene Monica Depui
Adam Rosinski
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9500422A priority Critical patent/SE9500422D0/sv
Publication of SE9500422D0 publication Critical patent/SE9500422D0/sv
Priority to ZA96365A priority patent/ZA96365B/xx
Priority to TW085100582A priority patent/TW474825B/zh
Priority to HR9500422-2A priority patent/HRP960032A2/hr
Priority to KR1019960705556A priority patent/KR100399524B1/ko
Priority to US08/628,712 priority patent/US6136344A/en
Priority to DE69621885T priority patent/DE69621885T2/de
Priority to AT96902558T priority patent/ATE219377T1/de
Priority to AU46822/96A priority patent/AU689372B2/en
Priority to NZ301408A priority patent/NZ301408A/en
Priority to PCT/SE1996/000125 priority patent/WO1996024375A1/en
Priority to DK96902558T priority patent/DK0754061T3/da
Priority to TR96/00786T priority patent/TR199600786T1/xx
Priority to CN96190196A priority patent/CN1098104C/zh
Priority to PT96902558T priority patent/PT754061E/pt
Priority to BR9605111A priority patent/BR9605111A/pt
Priority to CA002186039A priority patent/CA2186039C/en
Priority to EE9600118A priority patent/EE9600118A/xx
Priority to MX9604354A priority patent/MX9604354A/es
Priority to ES96902558T priority patent/ES2176436T3/es
Priority to PL96316684A priority patent/PL316684A1/xx
Priority to CZ962931A priority patent/CZ293196A3/cs
Priority to JP52419096A priority patent/JP3699122B2/ja
Priority to SK1260-96A priority patent/SK126096A3/sk
Priority to EP96902558A priority patent/EP0754061B1/en
Priority to HU9603064A priority patent/HUP9603064A2/hu
Priority to ARP960101281A priority patent/AR002275A1/es
Priority to TNTNSN96025A priority patent/TNSN96025A1/fr
Priority to IL11704196A priority patent/IL117041A/xx
Priority to MA24156A priority patent/MA23801A1/fr
Priority to YU7396A priority patent/YU7396A/sh
Priority to IS4360A priority patent/IS4360A/is
Priority to NO19964212A priority patent/NO316865B1/no
Priority to FI963984A priority patent/FI119174B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE9500422A 1995-02-06 1995-02-06 New oral pharmaceutical dosage forms SE9500422D0 (sv)

Priority Applications (34)

Application Number Priority Date Filing Date Title
SE9500422A SE9500422D0 (sv) 1995-02-06 1995-02-06 New oral pharmaceutical dosage forms
ZA96365A ZA96365B (en) 1995-02-06 1996-01-17 New oral pharmaceutical dosage form
TW085100582A TW474825B (en) 1995-02-06 1996-01-18 Novel oral pharmaceutical formulations with multiple unit tableted dosage form and their process for preparation
HR9500422-2A HRP960032A2 (en) 1995-02-06 1996-01-23 New oral pharmaceutical dosage form
HU9603064A HUP9603064A2 (en) 1995-02-06 1996-02-02 New oral pharmaceutical dosage form
CA002186039A CA2186039C (en) 1995-02-06 1996-02-02 New oral pharmaceutical dosage form
ES96902558T ES2176436T3 (es) 1995-02-06 1996-02-02 Nueva forma de dosificacion farmaceutica oral.
DE69621885T DE69621885T2 (de) 1995-02-06 1996-02-02 Neue galenische orale pharmazeutische formulierung
AT96902558T ATE219377T1 (de) 1995-02-06 1996-02-02 Neue galenische orale pharmazeutische formulierung
AU46822/96A AU689372B2 (en) 1995-02-06 1996-02-02 New oral pharmaceutical dosage form
NZ301408A NZ301408A (en) 1995-02-06 1996-02-02 Oral dosage formulation: antibacterial agent plus a proton pump inhibitor
PCT/SE1996/000125 WO1996024375A1 (en) 1995-02-06 1996-02-02 New oral pharmaceutical dosage form
DK96902558T DK0754061T3 (da) 1995-02-06 1996-02-02 Ny oral farmaceutisk doseringsform
TR96/00786T TR199600786T1 (tr) 1995-02-06 1996-02-02 Agiz yoluyla alinan yeni farmasötik dozaj formlari.
CN96190196A CN1098104C (zh) 1995-02-06 1996-02-02 新的口服药用剂型
PT96902558T PT754061E (pt) 1995-02-06 1996-02-02 Nova forma de dosagem farmaceutica oral
BR9605111A BR9605111A (pt) 1995-02-06 1996-02-02 Formulação de dosagem farmacêutica oral processo para a manufatura de uma formulação de dosagem fixa método para o tratamento de distúrbios com infecções por helicobacter pylori em mamiferos e no ser humano e uso de uma formulação de dosagem
KR1019960705556A KR100399524B1 (ko) 1995-02-06 1996-02-02 신규경구제약학상제형
EE9600118A EE9600118A (et) 1995-02-06 1996-02-02 Uus peroraalne farmatseutiline annusvorm
MX9604354A MX9604354A (es) 1995-02-06 1996-02-02 Nueva forma de dosis farmaceutica oral.
US08/628,712 US6136344A (en) 1995-02-06 1996-02-02 Oral pharmaceutical dosage form
PL96316684A PL316684A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutic preparation for oral applications
CZ962931A CZ293196A3 (en) 1995-02-06 1996-02-02 Oral pharmaceutical dosing form and process for preparing thereof
JP52419096A JP3699122B2 (ja) 1995-02-06 1996-02-02 新規な経口用の医薬使用形態
SK1260-96A SK126096A3 (en) 1995-02-06 1996-02-02 Oral pharmaceutical dosage form and manufacturing process thereof
EP96902558A EP0754061B1 (en) 1995-02-06 1996-02-02 New oral pharmaceutical dosage form
MA24156A MA23801A1 (fr) 1995-02-06 1996-02-05 Nouvelle presentation d'un produit destine a etre administre par voie buccale
ARP960101281A AR002275A1 (es) 1995-02-06 1996-02-05 Forma de dosificacion farmaceutica oral, procedimiento para la manufactura de una forma de dosificacion fija, y uso de dicha forma de dosificacionfarmaceutica oral.
TNTNSN96025A TNSN96025A1 (fr) 1995-02-06 1996-02-05 Nouvelle presentation pharmaceutique a voie buccale
IL11704196A IL117041A (en) 1995-02-06 1996-02-05 Oral pharmaceutical dosage forms comprising a proton pump inhibitor together with an antibacterial compound
YU7396A YU7396A (sh) 1995-02-06 1996-02-06 Oralni farmaceutski dozni oblik sa jednim inhibitorom protonske pumpe i najmanje jednim protivbakterijskim jedinjenjem i postupak za njegovu izradu
IS4360A IS4360A (is) 1995-02-06 1996-09-17 Lyfjablanda í skammtaformi til munninntöku
NO19964212A NO316865B1 (no) 1995-02-06 1996-10-04 Ny oral farmasoytisk doseringsform, fremgangsmate for dens fremstilling, og anvendelse derav
FI963984A FI119174B (sv) 1995-02-06 1996-10-04 Ny oral farmaceutisk doseringsform

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500422A SE9500422D0 (sv) 1995-02-06 1995-02-06 New oral pharmaceutical dosage forms
US46477595A 1995-06-07 1995-06-07

Publications (1)

Publication Number Publication Date
SE9500422D0 true SE9500422D0 (sv) 1995-02-06

Family

ID=26662219

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9500422A SE9500422D0 (sv) 1995-02-06 1995-02-06 New oral pharmaceutical dosage forms

Country Status (31)

Country Link
US (1) US6136344A (sv)
EP (1) EP0754061B1 (sv)
JP (1) JP3699122B2 (sv)
CN (1) CN1098104C (sv)
AR (1) AR002275A1 (sv)
AT (1) ATE219377T1 (sv)
AU (1) AU689372B2 (sv)
BR (1) BR9605111A (sv)
CA (1) CA2186039C (sv)
CZ (1) CZ293196A3 (sv)
DE (1) DE69621885T2 (sv)
DK (1) DK0754061T3 (sv)
EE (1) EE9600118A (sv)
ES (1) ES2176436T3 (sv)
FI (1) FI119174B (sv)
HR (1) HRP960032A2 (sv)
HU (1) HUP9603064A2 (sv)
IL (1) IL117041A (sv)
IS (1) IS4360A (sv)
MA (1) MA23801A1 (sv)
MX (1) MX9604354A (sv)
NO (1) NO316865B1 (sv)
NZ (1) NZ301408A (sv)
PL (1) PL316684A1 (sv)
PT (1) PT754061E (sv)
SE (1) SE9500422D0 (sv)
SK (1) SK126096A3 (sv)
TR (1) TR199600786T1 (sv)
TW (1) TW474825B (sv)
WO (1) WO1996024375A1 (sv)
ZA (1) ZA96365B (sv)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
SE9702000D0 (sv) * 1997-05-28 1997-05-28 Astra Ab New pharmaceutical formulation
SE510650C2 (sv) 1997-05-30 1999-06-14 Astra Ab Ny förening
CA2294117A1 (en) 1997-07-03 1999-01-14 Dupont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
SI9700186B (sl) * 1997-07-14 2006-10-31 Lek, Tovarna Farmacevtskih In Kemicnih Izdelkov, D.D. Nova farmacevtska oblika z nadzorovanim sproscanjem zdravilnih ucinkovin
WO1999010000A1 (en) * 1997-08-25 1999-03-04 The Procter & Gamble Company Combined preparations for treating upper gastrointestinal tract distress
US6174548B1 (en) * 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
PL196163B1 (pl) * 1997-12-08 2007-12-31 Altana Pharma Ag Nowa postać leku do podawania doustnego związków aktywnych nietrwałych w środowisku kwaśnym, zastosowanie jednostek związku aktywnego do wytwarzania leku do podawania doustnego oraz sposób wytwarzania nowej postaci leku do podawania doustnego
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
SE9704870D0 (sv) 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
EP1121103B1 (en) 1998-05-18 2006-12-20 Takeda Pharmaceutical Company Limited Orally disintegrable tablets comprising a benzimidazole
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
AR019935A1 (es) 1998-07-28 2002-03-27 Takeda Pharmaceutical Preparacion solida de desintegracion rapida, uso de una hidroxipropil celulosa poco sustituida en dicha preparacion y metodo para mejorar la capacidad dedesintegracion rapida de la misma
US6733778B1 (en) 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
DE19850445A1 (de) * 1998-11-02 2000-05-04 Falk Pharma Gmbh Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen
US6852739B1 (en) * 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
WO2000050037A1 (en) * 1999-02-26 2000-08-31 Nitromed, Inc. Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
FR2793688B1 (fr) * 1999-05-21 2003-06-13 Ethypharm Lab Prod Ethiques Microgranules gastroproteges, procede d'obtention et preparations pharmaceutiques
CA2413923A1 (en) * 2000-03-09 2001-09-13 Andrew Ilchyshyn Treatment of inflammatory dermatoses comprising erythromycin or clarythromycin metronidazole and a gastrointestinal hydrogen pump inhibitor
EP1133987A1 (en) * 2000-03-09 2001-09-19 Ian Whitcroft Treatment of inflammatory dermatoses with combinations of erythromycin or clarythromycin, metronidazole and a hydrogen pump inhibitor
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
SI20720A (sl) * 2000-11-20 2002-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nov farmacevtski pripravek v obliki celuloznih kapsul uporaben za derivate benzimidazola
FR2821745B1 (fr) * 2001-03-09 2004-07-02 Ethypharm Lab Prod Ethiques Granules et granules enrobes au gout masque
US8268333B2 (en) 2001-04-24 2012-09-18 Lintec Corporation Orally administered agent and an orally administered agent/supporting substrate complex
JP4993652B2 (ja) * 2004-03-31 2012-08-08 リンテック株式会社 経口投与剤
US20040156903A1 (en) * 2002-05-22 2004-08-12 Abrams Andrew L.. Metering and packaging of controlled release medication
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
ATE346590T1 (de) * 2001-07-26 2006-12-15 Ethypharm Sa Umgehüllte allylamine oder benzylamine enthaltende granulate, verfahren zur herstellung und in der mundhöhle dispergierbare tabletten enthaltend die umgehüllten granulate
WO2003063927A2 (en) * 2001-11-16 2003-08-07 Eisai Co. Ltd Compositions and methods to treat gastrointestinal disorders
ES2198195B1 (es) * 2001-12-18 2004-10-01 Laboratorios Del Dr. Esteve, S.A. Forma de dosificacion farmaceutica oral comprimida, con recubrimiento enterico, que contiene un compuesto de bencimidazol labil en medio acido.
WO2003063840A2 (en) * 2002-01-25 2003-08-07 Santarus, Inc. Transmucosal delivery of proton pump inhibitors
AU2002343199A1 (en) * 2002-05-28 2003-12-12 J.B. Chemicals And Pharmaceuticals Ltd. Formulations of erythromycin derivatives with improved bioavailability
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
US7211590B2 (en) 2002-08-01 2007-05-01 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
US7309444B2 (en) * 2002-08-29 2007-12-18 Stellar Technology Company Layered tablet water treatment compositions and method of use
US6852238B2 (en) * 2002-08-29 2005-02-08 Steller Technology Company Layered tablet water treatment compositions and method of use
FR2845289B1 (fr) * 2002-10-04 2004-12-03 Ethypharm Sa Spheroides, procede de preparation et compositions pharmaceutiques.
US9107804B2 (en) 2002-12-10 2015-08-18 Nortec Development Associates, Inc. Method of preparing biologically active formulations
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) * 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20070065513A1 (en) * 2003-10-31 2007-03-22 Avi Avramoff Stable lansoprazole formulation
JP2005298471A (ja) * 2004-03-17 2005-10-27 Lintec Corp 薬剤の製造方法
JP2005289867A (ja) * 2004-03-31 2005-10-20 Lintec Corp 経口投与剤
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2469427A1 (en) * 2004-06-01 2005-12-01 Pharmascience Inc. Dry mixed dosage form containing benzimidazole derivatives
US20070224269A1 (en) * 2004-06-10 2007-09-27 Rubino Orapin P Controlled Release Pharmaceutical Formulation
WO2006030297A1 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Taste masked granules comprising clarithromycin, hydrocolloids and a coating
CN100393304C (zh) * 2005-02-28 2008-06-11 上海艾力斯医药科技有限公司 一种包含酸不稳定药物的微细颗粒及其制剂
US7981908B2 (en) * 2005-05-11 2011-07-19 Vecta, Ltd. Compositions and methods for inhibiting gastric acid secretion
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion
CN100431526C (zh) * 2005-11-07 2008-11-12 上海艾力斯医药科技有限公司 一种酸敏感型药物的快速崩解片剂
EP1803450A1 (en) 2006-01-03 2007-07-04 Ferrer Internacional, S.A. Pharmaceutical compositions for the eradication of helicobacter pylori
WO2007122478A2 (en) * 2006-04-20 2007-11-01 Themis Laboratories Private Limited Multiple unit compositions
EP2026768B1 (en) * 2006-06-01 2018-02-28 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
EP2046334B1 (en) * 2006-07-25 2014-05-21 Vecta Ltd. Compositions and meth0ds for inhibiting gastric acide secretion using derivatives of small dicarboxylic acids in combination with ppi
US20090252787A1 (en) * 2006-07-28 2009-10-08 Dr. Reddy's Laboratories Ltd. Granular pharmaceutical compositions
RU2006132127A (ru) * 2006-09-06 2008-03-20 Государственное Учреждение Научный Центр Здоровьядетей Российской Академии Медицинских Наук (Гу Нцзд Рамн) (Ru) Применение нифуроксазида в качестве компонента комбинированной лекарственной терапии заболеваний, ассоциированных с helicobacter pylori, и способ лечения, направленный на эрадикацию возбудителя
CA2667682A1 (en) 2006-10-27 2008-05-15 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
US20080194307A1 (en) * 2007-02-13 2008-08-14 Jeff Sanger Sports-based game of chance
US20090087483A1 (en) * 2007-09-27 2009-04-02 Sison Raymundo A Oral dosage combination pharmaceutical packaging
US8439033B2 (en) 2007-10-09 2013-05-14 Microdose Therapeutx, Inc. Inhalation device
US20100260852A1 (en) * 2007-10-29 2010-10-14 Keiko Katsuki Laxative agent
FR2926724B1 (fr) * 2008-01-25 2010-06-18 Duo Ge Nouvelle forme pharmaceutique orale.
FR2926723B1 (fr) * 2008-01-25 2010-06-18 Duo Ge Associations pharmaceutiques orales.
BRPI0907414A2 (pt) * 2008-01-25 2019-02-26 Duo-Ge forma oral de dosagem farmacêutica contendo pelo menos dois medicamentos
CN101980700A (zh) 2008-02-20 2011-02-23 密苏里大学董事会 包含奥美拉唑和兰索拉唑以及缓冲剂的组合的组合物及其使用方法
TWI519322B (zh) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
WO2010018593A2 (en) * 2008-07-03 2010-02-18 Torrent Pharmaceuticals Ltd. Gastric acid resistant benzimidazole multiple unit tablet composition
WO2010029335A1 (en) * 2008-09-09 2010-03-18 Astrazeneca Uk Limited Method for delivering a pharmaceutical composition to patient in need thereof
CA2764963C (en) 2009-06-25 2016-11-01 Astrazeneca Ab Method for treating a patient at risk for developing an nsaid-associated ulcer
US8991390B2 (en) 2010-01-05 2015-03-31 Microdose Therapeutx, Inc. Inhalation device and method
IT1400415B1 (it) * 2010-05-26 2013-05-31 Over S R L Composizioni per il trattamento della infezione da helicobacter pylori.
WO2012075015A2 (en) * 2010-11-29 2012-06-07 Dr. Reddy's Laboratories Ltd. Oral metronidazole pharmaceutical compositions
EP2601947A1 (en) * 2011-12-05 2013-06-12 Abo Bakr Mohammed Ali Al-Mehdar Fixed-dose combination for treatment of helicobacter pylori associated diseases
EP2797600A4 (en) 2011-12-28 2015-09-16 Pozen Inc IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID
ES2744406T3 (es) * 2013-02-13 2020-02-25 Redhill Biopharma Ltd Composiciones farmacéuticas para el tratamiento de helicobacter pylori
US20170182070A1 (en) 2014-10-08 2017-06-29 Mayne Pharma International Pty Ltd. Controlled Release Doxycycline
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
EP3496714A4 (en) 2016-08-11 2020-04-22 Adamis Pharmaceuticals Corporation DRUG COMPOSITIONS.
EP3720844A4 (en) 2017-12-08 2021-08-11 Adamis Pharmaceuticals Corporation MEDICINAL COMPOSITIONS
US11878011B2 (en) 2020-05-07 2024-01-23 Redhill Biopharma Ltd. Method for eradicating Helicobacter pylori infection in patients regardless of body mass index

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
JPS5598120A (en) * 1979-01-16 1980-07-25 Shin Etsu Chem Co Ltd Preparation of drug having enteric coating
FR2471186A1 (fr) * 1979-12-10 1981-06-19 Roussel Uclaf Nouveaux comprimes a delitescence colique, ainsi que leur procede de preparation
US4340582A (en) * 1981-01-15 1982-07-20 Abbott Laboratories Erythromycin base tablets
US4377568A (en) * 1981-08-12 1983-03-22 Merck Sharp & Dohme (I.A.) Corp. Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS5973529A (ja) * 1982-10-12 1984-04-25 Sankyo Co Ltd 被覆固形製剤の製造法
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
US4518433A (en) * 1982-11-08 1985-05-21 Fmc Corporation Enteric coating for pharmaceutical dosage forms
GB2132887A (en) * 1982-11-15 1984-07-18 Procter & Gamble Enteric-coated anti-inflammatory compositions
US4556552A (en) * 1983-09-19 1985-12-03 Colorcon, Inc. Enteric film-coating compositions
JPH0759499B2 (ja) * 1984-02-10 1995-06-28 ベンツォン ファーマ エイ／エス 拡散被覆された複合単位服用剤
US4568560A (en) * 1984-03-16 1986-02-04 Warner-Lambert Company Encapsulated fragrances and flavors and process therefor
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
AU4640985A (en) * 1984-08-31 1986-03-06 Nippon Chemiphar Co. Ltd. Benzimidazole derivatives
SE450087B (sv) * 1985-10-11 1987-06-09 Haessle Ab Korn med kontrollerad frisettning av farmaceutiskt aktiva emnen som anbringats teckande pa ett kompakt olosligt kernmaterial
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
EP0439453B1 (en) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
SE8803822D0 (sv) * 1988-10-26 1988-10-26 Novel dosage form
SE8804629D0 (sv) * 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
SE9002206D0 (sv) * 1990-06-20 1990-06-20 Haessle Ab New compounds
DE69131627T2 (de) * 1990-06-20 2000-04-27 Astra Ab Soedertaelje Dialkoxypyridinylbenzimidazolderivate, verfahren zur herstellung und ihre pharmazeutische verwendung
GB9018603D0 (en) * 1990-08-24 1990-10-10 Smith Kline French Lab Compositions
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
JP3142919B2 (ja) * 1991-11-06 2001-03-07 旭化成株式会社 セルロース誘導体ラテックス及びその製法
US5160742A (en) * 1991-12-31 1992-11-03 Abbott Laboratories System for delivering an active substance for sustained release
IS3990A (is) * 1992-04-24 1993-10-25 Ab Astra Aðferð við að blanda saman efni sem hindrar flæðimagasýru og bakteríueyðandi efnis sem brotnar niður í súru umhverfi
DE69331906T2 (de) * 1992-08-05 2002-12-19 F.H. Faulding & Co. Ltd., Underdale Granulierte pharmazeutische zusammensetzung
US5330759A (en) * 1992-08-26 1994-07-19 Sterling Winthrop Inc. Enteric coated soft capsules and method of preparation thereof
SE9301830D0 (sv) * 1993-05-28 1993-05-28 Ab Astra New compounds
US5424447A (en) * 1993-07-07 1995-06-13 The Medical College Of Wisconsin Research Foundation, Inc. Heme binding compounds and use thereof
EP0642797B1 (en) * 1993-09-09 2000-05-17 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
JP3017906B2 (ja) * 1993-10-08 2000-03-13 信越化学工業株式会社 腸溶性コーティング剤分散液
JP3710473B2 (ja) * 1993-10-12 2005-10-26 三菱ウェルファーマ株式会社 腸溶性顆粒含有錠剤
GB2285989A (en) * 1994-01-28 1995-08-02 Merck Frosst Canada Inc Aqueous formulations for enteric coatings
CZ289804B6 (cs) * 1994-07-08 2002-04-17 Astrazeneca Ab Multijednotková tabletovaná dávková forma I
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation

Also Published As

Publication number Publication date
DE69621885T2 (de) 2003-01-02
CA2186039A1 (en) 1996-08-15
FI963984A (sv) 1996-10-04
BR9605111A (pt) 1997-10-07
CA2186039C (en) 2005-06-07
IS4360A (is) 1996-09-17
NO964212D0 (no) 1996-10-04
CN1098104C (zh) 2003-01-08
ZA96365B (en) 1996-08-06
DE69621885D1 (de) 2002-07-25
DK0754061T3 (da) 2002-08-26
CN1148344A (zh) 1997-04-23
NZ301408A (en) 1998-07-28
ES2176436T3 (es) 2002-12-01
JP3699122B2 (ja) 2005-09-28
NO316865B1 (no) 2004-06-07
FI963984A0 (sv) 1996-10-04
AR002275A1 (es) 1998-03-11
NO964212L (no) 1996-10-04
HUP9603064A2 (en) 1997-08-28
TW474825B (en) 2002-02-01
IL117041A (en) 2000-07-16
AU4682296A (en) 1996-08-27
AU689372B2 (en) 1998-03-26
SK126096A3 (en) 1997-05-07
TR199600786T1 (tr) 1997-03-21
FI119174B (sv) 2008-08-29
IL117041A0 (en) 1996-06-18
JPH09511767A (ja) 1997-11-25
MA23801A1 (fr) 1996-10-01
CZ293196A3 (en) 1997-11-12
ATE219377T1 (de) 2002-07-15
EP0754061A1 (en) 1997-01-22
MX9604354A (es) 1997-06-28
EP0754061B1 (en) 2002-06-19
US6136344A (en) 2000-10-24
PL316684A1 (en) 1997-02-03
HRP960032A2 (en) 1997-10-31
PT754061E (pt) 2002-11-29
WO1996024375A1 (en) 1996-08-15
EE9600118A (et) 1997-04-15

Similar Documents

Publication Publication Date Title
SE9500422D0 (sv) New oral pharmaceutical dosage forms
SE9600072D0 (sv) New oral formulation of two active ingredients II
MY112915A (en) Multiple unit tableted dosage form 1
SE9600073D0 (sv) Multiple unit dosage form
MY119212A (en) Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a nsaid
MA23608A1 (fr) Forme de dosage ii d'unite multiple en comprime
SE9600071D0 (sv) New oral formulation of two active ingredients I
SE9700885D0 (sv) New pharmaceutical formulation
BR9506903A (pt) Tablete de paracetamol e domperidona revestido com película
TR199801184T2 (xx) Analjezik tesirli yeni bile�ikler.
EE9700366A (et) Angiotensiini II tüüp 1 retseptori antagonistide kasutamine düspeptiliste sümptomite profülaktikas ja/või ravis kasutatava ravimi valmistamiseks ja angiotensiini II tüüp 1 retseptori antagoniste sisaldavad ravimpreparaadid
SE9504267D0 (sv) New therapeutic use
JO1881B1 (en) Formula II for multi unit disc calibration
JO1880B1 (en) Format 1 for multi-unit calibration discs